These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16177274)

  • 1. The factorial structure of the schedule for the deficit syndrome in schizophrenia.
    Kimhy D; Yale S; Goetz RR; McFarr LM; Malaspina D
    Schizophr Bull; 2006 Apr; 32(2):274-8. PubMed ID: 16177274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delusions in individuals with schizophrenia: factor structure, clinical correlates, and putative neurobiology.
    Kimhy D; Goetz R; Yale S; Corcoran C; Malaspina D
    Psychopathology; 2005; 38(6):338-44. PubMed ID: 16269869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Categorical and dimensional approaches to negative symptoms of schizophrenia: focus on long-term stability and functional outcome.
    Galderisi S; Bucci P; Mucci A; Kirkpatrick B; Pini S; Rossi A; Vita A; Maj M
    Schizophr Res; 2013 Jun; 147(1):157-162. PubMed ID: 23608244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A two-factor structure for the Schedule for the Deficit Syndrome in schizophrenia.
    Nakaya M; Ohmori K
    Psychiatry Res; 2008 Mar; 158(2):256-9. PubMed ID: 18206248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disturbed functional connectivity within brain networks subserving domain-specific subcomponents of working memory in schizophrenia: relation to performance and clinical symptoms.
    Henseler I; Falkai P; Gruber O
    J Psychiatr Res; 2010 Apr; 44(6):364-72. PubMed ID: 19837416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal parietal cortex activation during working memory in schizophrenia: verbal phonological coding disturbances versus domain-general executive dysfunction.
    Barch DM; Csernansky JG
    Am J Psychiatry; 2007 Jul; 164(7):1090-8. PubMed ID: 17606661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced total antioxidant level and increased oxidative stress in patients with deficit schizophrenia: a preliminary study.
    Albayrak Y; Ünsal C; Beyazyüz M; Ünal A; Kuloğlu M
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():144-9. PubMed ID: 23657077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neural basis of the deficit syndrome of schizophrenia.
    Kirkpatrick B; Buchanan RW
    J Nerv Ment Dis; 1990 Sep; 178(9):545-55. PubMed ID: 2203878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes over time in frontotemporal activation during a working memory task in patients with schizophrenia.
    Wolf RC; Vasic N; Höse A; Spitzer M; Walter H
    Schizophr Res; 2007 Mar; 91(1-3):141-50. PubMed ID: 17258892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of deficit schizophrenia and reliability of the bidimensional model of its negative symptomatology.
    López-Díaz Á; Menéndez-Sampil C; Pérez-Romero A; Palermo-Zeballos FJ; Valdés-Florido MJ
    Nord J Psychiatry; 2020 Aug; 74(6):400-406. PubMed ID: 32149549
    [No Abstract]   [Full Text] [Related]  

  • 11. Social brain dysfunctions in schizophrenia: a review of neuroimaging studies.
    Brunet-Gouet E; Decety J
    Psychiatry Res; 2006 Dec; 148(2-3):75-92. PubMed ID: 17088049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mental state attribution, neurocognitive functioning, and psychopathology: what predicts poor social competence in schizophrenia best?
    Brüne M; Abdel-Hamid M; Lehmkämper C; Sonntag C
    Schizophr Res; 2007 May; 92(1-3):151-9. PubMed ID: 17346931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Alexithymia in negative symptom and non-negative symptom schizophrenia].
    Nkam I; Langlois-Thery S; Dollfus S; Petit M
    Encephale; 1997; 23(5):358-63. PubMed ID: 9453928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automatic affective processing impairments in patients with deficit syndrome schizophrenia.
    Strauss GP; Allen DN; Duke LA; Ross SA; Schwartz J
    Schizophr Res; 2008 Jul; 102(1-3):76-87. PubMed ID: 18313270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
    Semkovska M; Bédard MA; Stip E
    Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olfactory identification and WAIS-R performance in deficit and nondeficit schizophrenia.
    Seckinger RA; Goudsmit N; Coleman E; Harkavy-Friedman J; Yale S; Rosenfield PJ; Malaspina D
    Schizophr Res; 2004 Jul; 69(1):55-65. PubMed ID: 15145471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptoms, subtype, and suicidality in patients with schizophrenia spectrum disorders.
    Fenton WS; McGlashan TH; Victor BJ; Blyler CR
    Am J Psychiatry; 1997 Feb; 154(2):199-204. PubMed ID: 9016268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
    Bobes J; Arango C; Garcia-Garcia M; Rejas J;
    J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A forced five-dimensional factor analysis and concurrent validity of the Positive and Negative Syndrome Scale in Mexican schizophrenic patients.
    Fresán A; De la Fuente-Sandoval C; Loyzaga C; García-Anaya M; Meyenberg N; Nicolini H; Apiquian R
    Schizophr Res; 2005 Jan; 72(2-3):123-9. PubMed ID: 15560957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Considering DSM-5: personality diagnostics in patients with schizophrenia spectrum disorders.
    Schroeder K; Hoppe A; Andresen B; Naber D; Lammers CH; Huber CG
    Psychiatry; 2012; 75(2):120-34. PubMed ID: 22642432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.